Soichiro Kiyono
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma.
Journal: Biochemical pharmacology
Published: October 25, 2024
Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.
Journal: Liver cancer
Published: May 20, 2024
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 27, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Journal: Investigational new drugs
Published: March 12, 2024
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.
Journal: Liver cancer
Published: January 03, 2024
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
Journal: Journal of gastroenterology
Published: August 24, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.
Journal: Drugs - real world outcomes
Published: June 19, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 19, 2023
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
Journal: Scientific reports
Published: March 24, 2023
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.
Journal: Scientific reports
Published: January 08, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Journal: Anticancer research
Published: December 06, 2022
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
Journal: Biochemical and biophysical research communications
Published: November 17, 2022
Last Updated: 09/26/2026